Status:
COMPLETED
Treatment of Fibromyalgia With Recovery Factors
Lead Sponsor:
Practitioners Alliance Network
Conditions:
Fibromyalgia
Chronic Fatigue Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Treatment of Fibromyalgia and CFS with Recovery Factors
Detailed Description
Use of a unique oral porcine peptide nutritional supplement in those meeting ACR 2010(amended) diagnostic criteria for Fibromyalgia or CDC Criteria for CFS
Eligibility Criteria
Inclusion
- Meet the ACR 2010 Amended Fibromyalgia Diagnostic Criteria or CFS CDC criteria; Score 5 or less on Energy VAS
Exclusion
- Under 18 Pregnant Other severe complicating conditions
- \-
Key Trial Info
Start Date :
May 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04381780
Start Date
May 6 2020
End Date
January 15 2021
Last Update
October 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jacob Teitelbaum MD
Kailua, Hawaii, United States, 96740